Investor List:

Top BioTech Series B Investors in New York City (150)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top BioTech investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Hiro Nozawa, Managing Director at Asahi Media Lab Ventures
Hiro Nozawa
Asahi Media Lab Ventures·Managing Director
Sweet spot: $250K
Range: $10K - $1M
Investors in San Francisco (CA), Investors in New York (NY)
Investors in Security (Seed), Investors in BioTech (Seed), Investors in IoT (Seed), Investors in AR/VR (Seed), Investors in Entertainment & Sports (Seed), Investors in Gaming/eSports (Seed), Investors in Analytics (Seed), Investors in Entertainment & Sports (Seed), Investors in Media/Content (Seed), Investors in AR/VR (Seed), Investors in Entertainment & Sports (Seed), Investors in AR/VR (Seed), Investors in Gaming/eSports (Seed), Investors in Analytics (Seed), Investors in FinTech (Seed), Investors in Security (Seed), Investors in IoT (Seed), Investors in Analytics (Seed), Investors in IoT (Seed), Investors in Gaming/eSports (Seed), Investors in Security (Seed), Investors in Media/Content (Seed), Investors in Media/Content (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in FinTech (Seed), Investors in AR/VR (Series A), Investors in BioTech (Series A), Investors in Security (Series A), Investors in Entertainment & Sports (Series A), Investors in IoT (Series A), Investors in Gaming/eSports (Series A), Investors in AR/VR (Series A), Investors in Entertainment & Sports (Series A), Investors in Analytics (Series A), Investors in AR/VR (Series A), Investors in Media/Content (Series A), Investors in Entertainment & Sports (Series A), Investors in Gaming/eSports (Series A), Investors in FinTech (Series A), Investors in IoT (Series A), Investors in Analytics (Series A), Investors in IoT (Series A), Investors in Gaming/eSports (Series A), Investors in Security (Series A), Investors in Analytics (Series A), Investors in Security (Series A), Investors in Media/Content (Series A), Investors in BioTech (Series A), Investors in Media/Content (Series A), Investors in BioTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Series A), Investors in Entertainment & Sports (Series B), Investors in BioTech (Series B), Investors in Security (Series B), Investors in AR/VR (Series B), Investors in Entertainment & Sports (Series B), Investors in Entertainment & Sports (Series B), Investors in Gaming/eSports (Series B), Investors in IoT (Series B), Investors in Analytics (Series B), Investors in AR/VR (Series B), Investors in Media/Content (Series B), Investors in AR/VR (Series B), Investors in Gaming/eSports (Series B), Investors in FinTech (Series B), Investors in Analytics (Series B), Investors in Analytics (Series B), Investors in Gaming/eSports (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in Media/Content (Series B), Investors in Media/Content (Series B), Investors in Security (Series B), Investors in Security (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in FinTech (Series B), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
EP
Emilie Poteat
Gaingels·Venture Partner
Sweet spot: $350K
Range: $200K - $500K
Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in New York (NY)
Investors in Education (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Education (Seed), Investors in FinTech (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in SaaS (Seed), Investors in Education (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in Education (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in FinTech (Seed), Investors in Consumer Internet (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in Consumer Internet (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Education (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Education (Series B), Investors in FinTech (Series B), Investors in Consumer Internet (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in Education (Series B), Investors in FinTech (Series B), Investors in SaaS (Series B), Investors in Consumer Internet (Series B), Investors in AI (Series B), Investors in Education (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in FinTech (Series B), Investors in FinTech (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in SaaS (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in SaaS (Series B), Investors in Los Angeles / Southern California (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Lonne Jaffe, Managing Director at Insight Partners
Lonne Jaffe
Insight Partners·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Investors in Retail (Series A), Investors in BioTech (Series A), Investors in Security (Series A), Investors in Education (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Data Services (Series A), Investors in Developer Tools (Series A), Investors in Retail (Series A), Investors in Education (Series A), Investors in Security (Series A), Investors in Enterprise (Series A), Investors in Consumer Internet (Series A), Investors in Developer Tools (Series A), Investors in BioTech (Series A), Investors in Data Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Series A), Investors in BioTech (Series B), Investors in Retail (Series B), Investors in Security (Series B), Investors in Health IT (Series B), Investors in Education (Series B), Investors in Health & Hospital Services (Series B), Investors in Developer Tools (Series B), Investors in Data Services (Series B), Investors in Education (Series B), Investors in Retail (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in Security (Series B), Investors in Developer Tools (Series B), Investors in BioTech (Series B), Investors in Data Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Consumer Internet (Series B), Investors in Enterprise (Series B), Investors in New York City (Other Lists)
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Manufacturing (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Manufacturing (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Manufacturing (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in Manufacturing (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Manufacturing (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Jonathan Mo, Principal at Alumni Ventures
Jonathan Mo
Alumni Ventures ·Principal
Sweet spot: $1M
Range: $50K - $5.0M
Investors in New York (NY)
Investors in EnergyTech (Seed), Investors in DeepTech (Seed), Investors in Space (Seed), Investors in Manufacturing (Seed), Investors in Hardware (Seed), Investors in Insurance (Seed), Investors in BioTech (Seed), Investors in Space (Seed), Investors in Manufacturing (Seed), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in Hardware (Seed), Investors in AI (Seed), Investors in FinTech (Seed), Investors in Consumer Internet (Seed), Investors in Insurance (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in FinTech (Seed), Investors in DeepTech (Series A), Investors in Space (Series A), Investors in Hardware (Series A), Investors in EnergyTech (Series A), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Insurance (Series A), Investors in Space (Series A), Investors in Manufacturing (Series A), Investors in DeepTech (Series A), Investors in EnergyTech (Series A), Investors in Hardware (Series A), Investors in AI (Series A), Investors in FinTech (Series A), Investors in Consumer Internet (Series A), Investors in Insurance (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in FinTech (Series A), Investors in Consumer Internet (Series A), Investors in Space (Series B), Investors in Hardware (Series B), Investors in DeepTech (Series B), Investors in EnergyTech (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in Space (Series B), Investors in Insurance (Series B), Investors in DeepTech (Series B), Investors in Manufacturing (Series B), Investors in Hardware (Series B), Investors in EnergyTech (Series B), Investors in AI (Series B), Investors in FinTech (Series B), Investors in Consumer Internet (Series B), Investors in BioTech (Series B), Investors in Insurance (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in FinTech (Series B), Investors in New York City (Other Lists)
Photo of Florence Evina- Ze, Vice President at Bain Capital
Florence Evina- Ze
Bain Capital·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY)
Investors in Enterprise Applications (Seed), Investors in BioTech (Seed), Investors in Insurance (Seed), Investors in Real Estate/PropTech (Seed), Investors in Web3/Crypto (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in E-commerce (Seed), Investors in Enterprise Applications (Seed), Investors in FinTech (Seed), Investors in Insurance (Seed), Investors in Enterprise (Seed), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in E-commerce (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Web3/Crypto (Seed), Investors in FinTech (Seed), Investors in Enterprise (Seed), Investors in Enterprise Applications (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in Insurance (Series A), Investors in Web3/Crypto (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in E-commerce (Series A), Investors in Enterprise Applications (Series A), Investors in FinTech (Series A), Investors in Enterprise (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in E-commerce (Series A), Investors in Insurance (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Web3/Crypto (Series A), Investors in FinTech (Series A), Investors in Enterprise (Series A), Investors in BioTech (Series B), Investors in Web3/Crypto (Series B), Investors in Real Estate/PropTech (Series B), Investors in Insurance (Series B), Investors in Enterprise Applications (Series B), Investors in E-commerce (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in FinTech (Series B), Investors in Enterprise Applications (Series B), Investors in Enterprise (Series B), Investors in E-commerce (Series B), Investors in Insurance (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Web3/Crypto (Series B), Investors in Health & Hospital Services (Series B), Investors in Real Estate/PropTech (Series B), Investors in Enterprise (Series B), Investors in FinTech (Series B), Investors in New York City (Other Lists)
Photo of Daisy Wolf, Partner at Andreessen Horowitz
Daisy Wolf
Sweet spot: $20.0M
Range: $500K - $40.0M
Investors in New York (NY)
Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in FinTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in FinTech (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in FinTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in FinTech (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Health IT (Series B), Investors in FinTech (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in FinTech (Series B), Investors in New York City (Other Lists)
Photo of Morgan Cheatham, Vice President at Bessemer Venture Partners
Morgan Cheatham
Sweet spot: $25.0M
Range: $1M - $250.0M
Investors in New York (NY)
Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Marketplaces (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Enterprise (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Marketplaces (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in AI (Series A), Investors in Marketplaces (Series A), Investors in Digital Health (Series A), Investors in Enterprise (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Marketplaces (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Enterprise (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Marketplaces (Series B), Investors in AI (Series B), Investors in Enterprise (Series B), Investors in New York City (Other Lists)